A Fireside Chat with Our Investors: Why BenchSci is the Horse They’re Backing
Dennis Kavelman, Partner at Inovia Capital, and Matt Brennan, Partner at TCV, shared with us why they chose to lead BenchSci’s $63M Series C funding.
A Fireside Chat with Nobel Laureate Dr. Jennifer Doudna
We’re honored that Dr. Doudna, co-inventor of CRISPR/Cas 9 technology and Nobel Prize recipient, took the time to share her incredible story with us.